Press release
RAS-acting Agents Market Size Will Expected to Surpass US$ 13.4 Billion [by 2031], Growing at 4.2% CAGR - Transparency Market Research Inc.
RAS-acting Agents
The global RAS-acting agents market was valued at US$ 9.7 billion in 2022 and is projected to grow at a CAGR of 4.2% from 2023 to 2031. By the end of 2031, the market is expected to surpass US$ 13.4 billion. The increasing burden of hypertension, growing demand for combination therapies, and advancements in drug formulations are fueling market growth.
Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85539
Analyst Viewpoint
Industry experts anticipate steady growth in the RAS-acting agents market, driven by increasing healthcare expenditure, expanding generic drug production, and the rising adoption of combination therapies. However, patent expirations of key drugs, regulatory hurdles, and potential side effects associated with RAS inhibitors may present challenges to market expansion.
Market Demand and Key Drivers
Rising Prevalence of Hypertension and Cardiovascular Diseases: The growing number of patients with high blood pressure and cardiovascular conditions is driving demand for RAS inhibitors.
Increasing Geriatric Population: Elderly individuals are more susceptible to hypertension, fueling market demand.
Growing Adoption of Combination Therapies: The preference for fixed-dose combinations of RAS inhibitors with other antihypertensive agents is increasing.
Expanding Generic Drug Market: The expiration of patents for blockbuster RAS inhibitors is leading to the entry of cost-effective generic alternatives.
Advancements in Drug Formulations: Innovations in extended-release and combination formulations are enhancing patient compliance and treatment outcomes.
Government Initiatives for Hypertension Management: Public health campaigns and awareness programs are promoting early diagnosis and treatment adherence.
Recent Developments
2023, Novartis: Launched a new combination therapy incorporating RAS inhibitors for hypertension management.
2023, Pfizer: Expanded its cardiovascular drug portfolio with the acquisition of a leading hypertension drug manufacturer.
2024, Merck & Co.: Received regulatory approval for a novel RAS-acting agent with improved safety profile.
2024, AstraZeneca: Partnered with healthcare organizations to improve access to antihypertensive therapies in emerging markets.
2024, Sanofi: Introduced a biosimilar version of a widely used angiotensin receptor blocker.
Key Market Players
Novartis AG
Pfizer, Inc.
AstraZeneca plc
Merck & Co., Inc.
Sanofi S.A.
Bristol-Myers Squibb Company
Daiichi Sankyo Company, Limited
Takeda Pharmaceutical Company Limited
Boehringer Ingelheim GmbH
Johnson & Johnson
Other Prominent Players
Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85539
Future Market Analysis
The RAS-acting agents market is expected to maintain a steady growth trajectory, driven by rising awareness of hypertension management, continuous innovation in drug formulations, and expanding access to affordable treatments. The development of next-generation RAS inhibitors and biosimilars will further enhance market opportunities, while strategic collaborations among pharmaceutical companies will accelerate drug discovery and commercialization efforts.
Market Trends and Opportunities
Shift Towards Personalized Medicine: Tailored treatment approaches based on genetic and phenotypic profiling are improving patient outcomes.
Growth in Fixed-Dose Combination Therapies: The increasing preference for single-pill combinations is enhancing treatment adherence.
Expansion in Emerging Markets: Developing regions are witnessing rising demand for affordable antihypertensive medications.
Development of Novel RAS-acting Agents: Research on next-generation inhibitors with enhanced efficacy and reduced side effects is ongoing.
Increasing Healthcare Investments: Government and private sector funding in cardiovascular healthcare is supporting market growth.
Market Segmentation
By Drug Class:
ACE Inhibitors
Angiotensin Receptor Blockers (ARBs)
Direct Renin Inhibitors
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Application:
Hypertension
Heart Failure
Chronic Kidney Disease
Others
Regional Analysis
North America: The largest market due to high disease prevalence, advanced healthcare infrastructure, and strong regulatory support.
Europe: Significant growth driven by increasing adoption of generic drugs and combination therapies.
Asia-Pacific: The fastest-growing region due to rising cardiovascular disease burden and improving healthcare accessibility.
Latin America & Middle East/Africa: Emerging markets with increasing healthcare spending and demand for affordable RAS-acting agents.
Explore Latest Research Reports by Transparency Market Research:
Hormone Replacement Therapy Market: https://www.pharmiweb.com/press-release/2025-03-12/hormone-replacement-therapy-market-to-reach-us-388-billion-by-2034-driven-by-increasing-demand-for-menopause-and-endocrine-disorder-treatments-tm
Sexually Transmitted Diseases (STD) Diagnostics Market: https://www.pharmiweb.com/press-release/2025-03-12/sexually-transmitted-diseases-std-diagnostics-market-to-exceed-us-159-billion-by-2034-fueled-by-innovation-and-rising-awareness-tmr-insights
Contact Us:
Transparency Market Research Inc.
Headquarters Downtown,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Phone: +1-518-618-1030
US - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RAS-acting Agents Market Size Will Expected to Surpass US$ 13.4 Billion [by 2031], Growing at 4.2% CAGR - Transparency Market Research Inc. here
News-ID: 3935557 • Views: …
More Releases from Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for RAS
Ras Al Khaimah's Trusted Physiotherapy Service
Unlock Your Body's Potential with Physio Home Professional Physiotherapy Services
At Physio Home in Ras Al Khaimah, we understand the pivotal role that physiotherapy plays in enhancing one's quality of life. Our dedicated team of experts is committed to providing personalized care and effective solutions tailored to your unique needs. With a focus on empowering mobility and promoting holistic well-being, we bring top-tier physiotherapy services directly to your doorstep. Whether you're…
Ras Aquaculture Market Leading Players, Competitive Landscape, Strategy, Forecas …
Ras Aquaculture Market Overview:
Recirculating Aquaculture Systems (RAS) represent an innovative and sustainable approach to aquaculture, focusing on the intensive farming of aquatic organisms in a controlled environment. Unlike traditional aquaculture methods that rely heavily on large water bodies, RAS involves the continuous recirculation and treatment of water within a closed-loop system. This method significantly reduces water usage, minimizes environmental impact, and allows for year-round production regardless of external weather conditions.…
RAS Inhibitors Market Size, Share, Growth Analysis 2023
The global ras inhibitors market size was valued at USD x billion in 2022 and is poised to grow at a significant CAGR of x% during the forecast period 2023-29. Ongoing research and development efforts in the RAS-inhibitors agents market are expanding its scope. New drugs targeting various renin-angiotensin system components, such as renin, ACE, and angiotensin II receptors, are being explored. The market is also witnessing increased interest…
RAS Targeting Therapies Market, 2021-2031 by Roots
Roots Analysis has announced the addition of “RAS Targeting Therapies Market, 2021-2031” report to its list of offerings.
To order this 140+ page report, which features 95+ figures, please visit https://www.rootsanalysis.com/reports/ras-targeting-therapies-market.html
Key Inclusions
A detailed overview of the current market landscape of RAS targeting therapies, along with information on several relevant parameters, such as current status of development (marketed, clinical, pre-clinical and discovery), phase of development (phase III, phase II, phase I /…
RAS Luxury Oils Launches Eco drive Campaign
Luxury Natural Skincare and wellness brand promotes Sustainability for the Environment
One Bottle at a Time #RecyclewithRAS
New Delhi, 26th November 2018: “Farm to bottle’ luxury natural skincare and wellness brand RAS Luxury Oils has launched its eco drive campaign, #RecyclewithRAS to encourage customers, to promote the concept of three R’s -“Reduce, Reuse and Recycle”, and to regain the sustainability of the packaging among customers.
On returning 1 empty primary bottle…
The Kurchatov Institute Has Chosen 2X RAS
Kurchatov Institute - supported by Aflex Distribution - Has Chosen 2X Remote Application Server
"We are very positive about the adoption of a 2X solution. At the moment we are using 2X RAS for its main features: application delivery and load balancing. We are very satisfied with the seamless end-user experience and the high availability gained with the workload-based server load balancing. In future, we plan to use 2X RAS…
